Revenue Growth and Profitability Boost Financial Strength
Mumbai, February 1, 2025 – Prevest Denpro Limited (BSE: PREVEST) has reported a robust financial performance for the quarter ended December 31, 2024, showcasing a significant year-over-year (YoY) and quarter-over-quarter (QoQ) growth in revenue and net profit.
Key Financial Highlights (Standalone)
(All figures in ₹ lakh unless stated otherwise)
| Metric | Q3 FY25 | Q2 FY25 | Q3 FY24 | 9M FY25 | 9M FY24 | FY24 (Audited) |
|---|
| Revenue from Operations | 1,492.62 | 1,625.67 | 1,362.32 | 4,452.52 | 4,019.50 | 5,643.98 |
| Total Income | 1,602.39 | 1,732.23 | 1,430.27 | 4,755.28 | 4,221.68 | 5,930.14 |
| Total Expenses | 1,026.86 | 1,091.41 | 956.91 | 3,051.47 | 2,706.27 | 3,788.69 |
| Profit Before Tax (PBT) | 575.53 | 640.82 | 473.36 | 1,703.81 | 1,515.40 | 2,141.46 |
| Net Profit | 446.37 | 483.85 | 363.53 | 1,295.36 | 1,146.02 | 1,612.37 |
| Earnings Per Share (₹) | 3.72 | 4.03 | 3.03 | 10.79 | 9.55 | 13.44 |
Prevest Denpro has delivered
a 9.6% YoY increase in revenue and a
22.8% YoY increase in net profit for Q3 FY2025. On a QoQ basis, revenue showed a slight decline, but net profit remained strong due to controlled expenses.
Consolidated Financial Performance
The company, including its wholly owned subsidiary
Denvisio Biomed Limited, also posted
strong consolidated numbers, further reinforcing its growth trajectory.
| Metric | Q3 FY25 | Q2 FY25 | Q3 FY24 | 9M FY25 | 9M FY24 | FY24 (Audited) |
|---|
| Revenue from Operations | 1,494.68 | 1,627.09 | 1,362.45 | 4,457.33 | 4,019.38 | 5,642.89 |
| Total Income | 1,603.57 | 1,730.85 | 1,430.39 | 4,756.40 | 4,221.56 | 5,929.05 |
| Total Expenses | 1,021.79 | 1,093.06 | 956.94 | 3,046.53 | 2,715.81 | 3,778.83 |
| Profit Before Tax (PBT) | 581.78 | 637.79 | 473.45 | 1,709.87 | 1,505.75 | 2,143.22 |
| Net Profit | 452.61 | 481.53 | 363.63 | 1,300.41 | 1,136.37 | 1,613.69 |
| Earnings Per Share (₹) | 3.77 | 4.01 | 3.03 | 10.84 | 9.47 | 13.45 |
, with
a 9.7% YoY increase in revenue and
a 24.5% increase in net profit, highlighting the company’s ability to generate sustained profitability.
Key Business Insights
- Consistent Growth – Prevest Denpro continues to expand its market presence with a strong demand for dental and healthcare solutions.
- Operational Efficiency – Despite a minor dip in revenue compared to the previous quarter, cost optimization strategies have helped maintain profitability.
- Resilient Margins – Stable gross margins and an increase in net profit indicate a well-managed financial structure.
- Dividend Outlook – With a strong EPS growth, the company remains well-positioned to reward shareholders.
Auditor’s Report
Mittal & Associates conducted a limited review of the financial statements and found
no material discrepancies or misstatements. The auditors reaffirmed that the financial results complied with
SEBI’s Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.
Conclusion
Prevest Denpro Limited has delivered
another strong quarter of financial growth, reinforcing its position as a leading dental and medical product manufacturer. With
rising profitability, operational efficiency, and a solid financial outlook, the company remains well-poised for continued expansion in the coming quarters.
Stock Performance Outlook: Given the
strong earnings report, Prevest Denpro could attract increased investor interest, supporting
a potential upside in its stock price in the near term.